Oncology Enrollment Enhancement
Oncology drug developers face many challenges. With only around 5% of patients participating in clinical research, oncology studies struggle to recruit enough patients and keep them enrolled. New approaches to site and patient identification are needed. Data mining is a promising tool for protocol and trial optimization, patient recruitment and retention, and site selection. However, data alone is not enough.
PPD’s just-in-time approach to clinical trials has expanded the number of healthcare centers that are candidates for trials, while generating benefits for patients, physicians, and trial sponsors. The result is faster, more effective drug development.
To watch the webinar, please complete the form below. Fields marked with * are required.